Aurobindo will shell out $250 million to acquire drugmaker Lannett, shoring up the Indian drugmaker’s footprint in the U.S.

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Image source: Getty Images. What: Shares of Lannett Company, Inc. (NYSE: LCI), a midsized generic drugmaker, packed on 25.2% last month, according to data from S&P Global Market Intelligence.

PHILADELPHIA, Aug. 25, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2021 fourth quarter and full year ended June 30, 2021. "With the ...

Founded in 1942, Lannett Company is a Philadelphia-based developer, manufacturer, marketer, and distributor of generic pharmaceuticals for a broad spectrum of indications. The company has seen its ...

The company’s earnings per share and revenue from the same time last year were 64 cents and $170.91 million. While this drop seems like bad Lannett Company news, it isn’t.

About Lannett Company, Inc.: Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications.

Lannett Company had seen its market cap tumble from $2.5 billion in early 2015 to below $500 million, all before announcing in August 2018 that JSP was walking away.

In aggregate Lannett Company currently has a Zacks Value Score of A, putting it into the top 20% of all stocks we cover from this look. This makes Lannett Company a solid choice for value investors.

Lannett Company, Inc. (LCI) Q2 2022 Earnings Conference Call February 3, 2022 4:30 PM ETCompany ParticipantsRobert Jaffe – Investor RelationsTim Crew – ...

Welcome to the Lannett Company Fiscal 2021 Fourth Quarter and Full Year Financial Results Conference Call. My name is Adrianne, and I will be your operator for today's call.